TAK-019

· Takeda

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TAK-019, covering 2023-06-06 to 2023-07-28. Get the full timeline:

Most recent: Clinical Trial Update: A Single Heterologous Booster Vaccination Study of TAK-019 in Healthy Japanese Adults (COVID-19) [Phase 3]